{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:22:03Z","timestamp":1758709323800,"version":"3.40.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.antiviral.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T03:46:35Z","timestamp":1363837595000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge"],"prefix":"10.1016","volume":"98","author":[{"given":"Brian B.","family":"Gowen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionna","family":"Scharton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachery","family":"Vest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Skirpstunas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.03.009_b0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.03.009_b0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.antiviral.2013.03.009_b0015","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.03.009_b0020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.03.009_b0025","first-page":"73","article-title":"Rift Valley fever outbreak\u2013Kenya, November 2006\u2013January 2007","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.antiviral.2013.03.009_b0030","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/AAC.00376-12","article-title":"Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201)","volume":"56","author":"Gowen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.03.009_b0035","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.03.009_b0040","doi-asserted-by":"crossref","first-page":"e1529","DOI":"10.1371\/journal.pntd.0001529","article-title":"Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse","volume":"6","author":"Gray","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2013.03.009_b0045","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.03.009_b0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2013.03.009_b0055","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.009_b0060","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.009_b0065","doi-asserted-by":"crossref","first-page":"e25027","DOI":"10.1371\/journal.pone.0025027","article-title":"Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice","volume":"6","author":"Jansen van Vuren","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2013.03.009_b0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.03.009_b0075","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.009_b0080","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/JVI.00778-12","article-title":"The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine","volume":"86","author":"Lihoradova","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.009_b0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"McElroy","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.03.009_b0090","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2013.03.009_b0095","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2013.03.009_b0100","unstructured":"NIAID, 2006. National Institute of Allergy and Infectious Diseases Biodefense Research Agenda for CDC Category A Agents, In: NIAID (Ed.). NIAID, Bethesda, MD."},{"key":"10.1016\/j.antiviral.2013.03.009_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2013.03.009_b0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.03.009_b0115","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2013.03.009_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2008.09.007","article-title":"Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea","volume":"81","author":"Rusnak","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.03.009_b0125","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2174\/092986706778773059","article-title":"Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research","volume":"13","author":"Russmann","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.03.009_b0130","series-title":"Fields Virology","first-page":"1741","article-title":"Bunyaviridae","author":"Schmaljohn","year":"2007"},{"key":"10.1016\/j.antiviral.2013.03.009_b0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","article-title":"The pathogenesis of Rift Valley fever virus in the mouse model","volume":"407","author":"Smith","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.03.009_b0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1603\/ME10007","article-title":"Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus","volume":"47","author":"Turell","year":"2010","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.antiviral.2013.03.009_b0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.1994.tb19867.x","article-title":"Rift Valley fever virus ecology and the epidemiology of disease emergence","volume":"750","author":"Wilson","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:16:40Z","timestamp":1745975800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0166354213000636"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}